Cargando…
Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology
SIMPLE SUMMARY: The lack of early diagnosis and the absence of suitable biomarkers coupled with resistance to available therapeutic options render pancreatic cancer one of the deadliest cancer types. Therefore, new therapeutic approaches are needed to be developed, taking into account the genetic an...
Autores principales: | Leroux, Cédric, Konstantinidou, Georgia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918504/ https://www.ncbi.nlm.nih.gov/pubmed/33672917 http://dx.doi.org/10.3390/cancers13040799 |
Ejemplares similares
-
Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018) -
Current and future roles of biosimilars in oncology practice
por: Konstantinidou, Sofia, et al.
Publicado: (2020) -
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy
por: Rossi Sebastiano, Matteo, et al.
Publicado: (2019) -
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy
por: Saliakoura, Maria, et al.
Publicado: (2023) -
Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography
por: Martinez, Daniel Sierra-Lara, et al.
Publicado: (2022)